Literature DB >> 23490383

Lack of evidence of hepatitis E virus infection among renal transplant recipients in a disease-endemic area.

A Naik1, N Gupta, D Goel, S K Ippagunta, R K Sharma, R Aggarwal.   

Abstract

Persistent hepatitis E virus (HEV) infection has been reported among solid-organ transplant recipients in nonendemic areas. Such chronic infections have all been related to genotype 3 HEV, which is prevalent in these areas. Whether persistent infection occurs with genotype 1 HEV, prevalent in areas where the infection is hyperendemic, is unclear. We therefore tested sera from renal transplant recipients receiving immunosuppressive agents in India, where genotype 1 HEV infection is endemic, for alanine aminotransferase levels, and presence of IgM and IgG anti-HEV antibodies and HEV RNA. Of the 205 subjects studied [aged 16-65 (median, 38) years, 182 male], 46 (22.4%) had abnormal ALT levels (>40 IU/mL). IgG anti-HEV was detected in 52 (20.5%) and IgM anti-HEV was detected in 14 (6.8%) subjects, including four who had IgG anti-HEV; antibody positivity had no relation with serum ALT or serum creatinine. All the sera tested were negative for HEV RNA. These findings suggest that chronic infection with genotype 1 HEV is infrequent.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23490383     DOI: 10.1111/jvh.12027

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  16 in total

1.  Lack of persistent hepatitis E virus infection as a cause for unexplained transaminase elevation in renal transplant recipients in India.

Authors:  Sachin Munjal; Neha Gupta; Raj K Sharma; Amit Gupta; Narain Prasad; Anupama Kaul; Dharmendra Bhadauria; Amit Goel; Rakesh Aggarwal
Journal:  Indian J Gastroenterol       Date:  2014-10-01

2.  Hepatitis E Virus.

Authors:  Georg Pauli; Martin Aepfelbacher; Ursula Bauerfeind; Johannes Blümel; Reinhard Burger; Barbara Gärtner; Albrecht Gröner; Lutz Gürtler; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Ruth Offergeld; Uwe Schlenkrich; Volkmar Schottstedt; Rainer Seitz; Johanna Strobel; Hannelore Willkommen; Sally A Baylis
Journal:  Transfus Med Hemother       Date:  2015-06-01       Impact factor: 3.747

Review 3.  Natural History, Clinical Manifestations, and Pathogenesis of Hepatitis E Virus Genotype 1 and 2 Infections.

Authors:  Rakesh Aggarwal; Amit Goel
Journal:  Cold Spring Harb Perspect Med       Date:  2019-07-01       Impact factor: 6.915

Review 4.  Hepatitis E virus infection.

Authors:  Nassim Kamar; Harry R Dalton; Florence Abravanel; Jacques Izopet
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

5.  Prevalence of hepatitis E virus viremia and antibodies among healthy blood donors in India.

Authors:  Harshita Katiyar; Amit Goel; Atul Sonker; Vishwajeet Yadav; Sadul Sapun; Rajendra Chaudhary; Rakesh Aggarwal
Journal:  Indian J Gastroenterol       Date:  2018-08-29

6.  Absence of chronic hepatitis E virus infection in liver transplant recipients: Report from a hyperendemic region.

Authors:  Pragya Agarwala; Ekta Gupta; Manish Chandra Choudhary; Viniyendra Pamecha
Journal:  Indian J Gastroenterol       Date:  2018-03-19

Review 7.  Hepatitis E in Germany--an under-reported infectious disease.

Authors:  Sven Pischke; Patrick Behrendt; Claus-Thomas Bock; Wolfgang Jilg; Michael P Manns; Heiner Wedemeyer
Journal:  Dtsch Arztebl Int       Date:  2014-09-01       Impact factor: 5.594

Review 8.  Hepatitis E virus in developed countries: one of the most successful zoonotic viral diseases in human history?

Authors:  Harry R Dalton; M Saunders; Kathy L Woolson
Journal:  J Virus Erad       Date:  2015-01-01

9.  Hepatitis E In Transplant Recipients: Why Is This Not A Problem In Japan?

Authors:  Sven Pischke; Heiner Wedemeyer
Journal:  EBioMedicine       Date:  2015-11-10       Impact factor: 8.143

10.  Hepatitis E in Transplantation.

Authors:  Olivier Marion; Florence Abravanel; Sebastien Lhomme; Jacques Izopet; Nassim Kamar
Journal:  Curr Infect Dis Rep       Date:  2016-03       Impact factor: 3.663

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.